Therapies
Sunday, May 4th, 2014
STROKEAHA: April 8, 2014 Background and Purpose—The benefits of intravenous tissue-type plasminogen activator in acute ischemic stroke are time dependent, and several strategies have been reported to be associated with more rapid door-to-needle (DTN) times. However, the extent to which hospitals are using these strategies and their association with DTN times have not been well studied. […]
Therapies
Sunday, May 4th, 2014
ACC: MARCH 27, 2014 Washington, D.C. (March 27, 2014) – Citing accelerating healthcare costs and finite resources, the American College of Cardiology and the American Heart Association announced they will begin incorporating value assessments into their clinical documents. The ACC and AHA elaborated on their decision, outlining the reasons for adding value assessments, reviewing the economic […]
Therapies
Sunday, May 4th, 2014
The Lancet Neurology: March 25, 2014 Most in-hospital deaths of patients with stroke, traumatic brain injury, or postanoxic encephalopathy after cardiac arrest occur after a decision to withhold or withdraw life-sustaining treatments. Decisions on treatment restrictions in these patients are generally complex and are based only in part on evidence from published work. Prognostic models to […]
Therapies
Sunday, May 4th, 2014
Implementation Science: March 11, 2014 Background Quality improvement collaboratives (QICs) continue to be widely used, yet evidence for their effectiveness is equivocal. We sought to explain what happened in Stroke 90:10, a QIC designed to improve stroke care in 24 hospitals in the North West of England. Our study drew in part on the literature on […]
News
Sunday, May 4th, 2014
HealthDay: Apr 7, 2014 MONDAY, April 7, 2014 (HealthDay News) — Early signs and symptoms of stroke are often missed by emergency department doctors, a new study finds. Every year, tens of thousands of Americans with symptoms such as dizziness or headache are misdiagnosed in the ER in the days or weeks before they suffer a […]
News
Sunday, May 4th, 2014
The Lancet Neurology: 4/1/14 Driven by innovative technologies, novel analytical methods, and collaborations unimaginable not long ago, our understanding of the role of genetic variation in stroke has advanced substantially in recent years. However, a vast amount of data have accumulated quickly, and increasingly complex methodologies used in studies make keeping up to date on relevant […]
News
Sunday, May 4th, 2014
The Lancet Neurology: March 28, 2014 The most common neuropsychiatric outcomes of stroke are depression, anxiety, fatigue, and apathy, which each occur in at least 30% of patients and have substantial overlap of prevalence and symptoms. Emotional lability, personality changes, psychosis, and mania are less common but equally distressing symptoms that are also challenging to […]
News
Saturday, May 3rd, 2014
The Lancet Neurology: February 28, 2014 Background It is often assumed that blood pressure increases acutely after major stroke, resulting in so-called post-stroke hypertension. In view of evidence that the risks and benefits of blood pressure-lowering treatment in acute stroke might differ between patients with major ischaemic stroke and those with primary intracerebral haemorrhage, we compared […]
